Skip to content
Duke University Office for Translation & Commercialization
  • By The Numbers
  • Start-Ups
  • DCP data
  • Stories
  • Archive
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018

Category: Start-Ups FY24

perseus therapeutics logo

Perseus Therapeutics

Posted on September 5, 2024 | by Marianne de Bedout Mora

Perseus Therapeutics is developing novel therapies for preventing hair loss in chemotherapy-treated cancer patients and for cosmetic use.

Posted in Start-Ups FY24
onvagus logo

OnVagus

Posted on September 5, 2024 | by Marianne de Bedout Mora

OnVagus is developing technologies for stimulating the vagus nerve for the treatment of cancer-associated cachexia.

Posted in Start-Ups FY24
neurophos logo

Neurophos

Posted on September 5, 2024 | by Marianne de Bedout Mora

Neurophos is developing AI computation solutions by combining optical metasurfaces and silicon photonics.

Posted in Start-Ups FY24
lucidigm therapeutics logo

Lucidigm Therapeutics

Posted on September 5, 2024 | by Marianne de Bedout Mora

Lucidigm Therapeutics is developing innovative immunomodulatory biologics for organ transplantation, gene therapy and autoimmune disease.

Posted in Start-Ups FY24
heureka logo

Heureka Labs

Posted on September 5, 2024 | by Marianne de Bedout Mora

Heureka Labs is developing gene summaries and data-driven hypotheses to help researchers accelerate discovery.

Posted in Start-Ups FY24
fullsteam health logo

Fullsteam Health

Posted on September 5, 2024 | by Marianne de Bedout Mora

Fullsteam Health is unlocking the ability for hospitals and health systems to achive value in clinical and operational decision-making through its software platform that automates the refinement of healthcare data into curated and actionable form.

Posted in Start-Ups FY24

Recent Posts

  • HealthLadder.AI
  • Lumotive Secures $45M to Accelerate Programmable Optics Growth
  • DANNCE.AI Raises $2.6M to Transform Neurological Assessments
  • Hands-On Workshop Guides Innovators through FDA-Regulated Markets
  • 10 Years of Duke Capital Partners

Recent Comments

    Archives

    • September 2025
    • September 2024
    • October 2023
    • October 2022

    Categories

    • Start-ups
    • Start-Ups FY23
    • Start-Ups FY24
    • Start-Ups FY25
    • Stories
    • Stories FY23
    • Stories FY24
    • Stories FY25

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
      Click here for enhanced color contrast.
    • Privacy Statement
    • © 2024 Duke Office for Translation & Commercialization